259 related articles for article (PubMed ID: 29182031)
1. Recent developments in d-α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy.
Tan S; Zou C; Zhang W; Yin M; Gao X; Tang Q
Drug Deliv; 2017 Nov; 24(1):1831-1842. PubMed ID: 29182031
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances of D-α-tocopherol Polyethylene Glycol 1000 Succinate Based Stimuli-responsive Nanomedicine for Cancer Treatment.
Guan Y; Wang LY; Wang B; Ding MH; Bao YL; Tan SW
Curr Med Sci; 2020 Apr; 40(2):218-231. PubMed ID: 32337683
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in the Application of Vitamin E TPGS for Drug Delivery.
Yang C; Wu T; Qi Y; Zhang Z
Theranostics; 2018; 8(2):464-485. PubMed ID: 29290821
[TBL] [Abstract][Full Text] [Related]
4. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells.
Li N; Fu T; Fei W; Han T; Gu X; Hou Y; Liu Y; Yang J
J Pharm Pharmacol; 2019 Aug; 71(8):1243-1254. PubMed ID: 31215039
[TBL] [Abstract][Full Text] [Related]
5. The applications of Vitamin E TPGS in drug delivery.
Guo Y; Luo J; Tan S; Otieno BO; Zhang Z
Eur J Pharm Sci; 2013 May; 49(2):175-86. PubMed ID: 23485439
[TBL] [Abstract][Full Text] [Related]
6. Copolymers of poly(lactic acid) and D-α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicines: versatile multifunctional platforms for cancer diagnosis and therapy.
Vijayakumar MR; Muthu MS; Singh S
Expert Opin Drug Deliv; 2013 Apr; 10(4):529-43. PubMed ID: 23316695
[TBL] [Abstract][Full Text] [Related]
7. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
[TBL] [Abstract][Full Text] [Related]
8. Induction of Mitochondrial Cell Death and Reversal of Anticancer Drug Resistance via Nanocarriers Composed of a Triphenylphosphonium Derivative of Tocopheryl Polyethylene Glycol Succinate.
Singh Y; Viswanadham KKDR; Pawar VK; Meher J; Jajoriya AK; Omer A; Jaiswal S; Dewangan J; Bora HK; Singh P; Rath SK; Lal J; Mishra DP; Chourasia MK
Mol Pharm; 2019 Sep; 16(9):3744-3759. PubMed ID: 31441308
[TBL] [Abstract][Full Text] [Related]
9. Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors.
Banerjee P; Geng T; Mahanty A; Li T; Zong L; Wang B
Int J Pharm; 2019 Feb; 557():374-389. PubMed ID: 30610896
[TBL] [Abstract][Full Text] [Related]
10. D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces cell cycle arrest and apoptosis selectively in Survivin-overexpressing breast cancer cells.
Neophytou CM; Constantinou C; Papageorgis P; Constantinou AI
Biochem Pharmacol; 2014 May; 89(1):31-42. PubMed ID: 24560876
[TBL] [Abstract][Full Text] [Related]
11. Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol.
Youk HJ; Lee E; Choi MK; Lee YJ; Chung JH; Kim SH; Lee CH; Lim SJ
J Control Release; 2005 Sep; 107(1):43-52. PubMed ID: 16081183
[TBL] [Abstract][Full Text] [Related]
12. Redefine the role of d-α-Tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein, multidrug resistance protein 1, and breast cancer resistance protein mediated cancer multidrug resistance.
Chen JY; Sung CJ; Chen SC; Hsiang YP; Hsu YC; Teng YN
Eur J Pharm Sci; 2023 Nov; 190():106579. PubMed ID: 37689120
[TBL] [Abstract][Full Text] [Related]
13. Effect of tocopheryl polyethylene glycol succinate on the percutaneous penetration of minoxidil from water/ethanol/polyethylene glycol 400 solutions.
Sheu MT; Wu AB; Lin KP; Shen CH; Ho HO
Drug Dev Ind Pharm; 2006 Jun; 32(5):595-607. PubMed ID: 16720414
[TBL] [Abstract][Full Text] [Related]
14. d-a-Tocopheryl Polyethylene Glycol 1000 Succinate and a small-molecule Survivin suppressant synergistically induce apoptosis in SKBR3 breast cancer cells.
Neophytou CM; Mesaritis A; Gregoriou G; Constantinou AI
Sci Rep; 2019 Oct; 9(1):14375. PubMed ID: 31591437
[TBL] [Abstract][Full Text] [Related]
15. TPGS Decorated Liposomes as Multifunctional Nano-Delivery Systems.
Farooq MA; Trevaskis NL
Pharm Res; 2023 Jan; 40(1):245-263. PubMed ID: 36376604
[TBL] [Abstract][Full Text] [Related]
16. Star-shaped polymer of β‑cyclodextrin-g-vitamin E TPGS for doxorubicin delivery and multidrug resistance inhibition.
Yang C; Qin Y; Tu K; Xu C; Li Z; Zhang Z
Colloids Surf B Biointerfaces; 2018 Sep; 169():10-19. PubMed ID: 29747026
[TBL] [Abstract][Full Text] [Related]
17. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ
Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859
[TBL] [Abstract][Full Text] [Related]
18. Comparison of poly(ε-caprolactone) chain lengths of poly(ε-caprolactone)-co-d-α-tocopheryl-poly(ethylene glycol) 1000 succinate nanoparticles for enhancement of quercetin delivery to SKBR3 breast cancer cells.
Suksiriworapong J; Phoca K; Ngamsom S; Sripha K; Moongkarndi P; Junyaprasert VB
Eur J Pharm Biopharm; 2016 Apr; 101():15-24. PubMed ID: 26802701
[TBL] [Abstract][Full Text] [Related]
19. D-α-tocopheryl polyethylene glycol 1000 succinate-containing vehicles provide no detectable chemoprotection from oxidative damage.
Baumgart BR; Van Vleet TR; Simic D; Salcedo TW; Lentz K; Donegan M; Davies MH; Bunch RT; Sanderson TP; Lange RW
J Appl Toxicol; 2015 Jul; 35(7):791-8. PubMed ID: 25348750
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in TPGS-based nanoparticles of docetaxel for improved chemotherapy.
Choudhury H; Gorain B; Pandey M; Kumbhar SA; Tekade RK; Iyer AK; Kesharwani P
Int J Pharm; 2017 Aug; 529(1-2):506-522. PubMed ID: 28711640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
